17.88
price down icon6.63%   -1.27
after-market Handel nachbörslich: 17.75 -0.13 -0.73%
loading

Biodesix Inc Aktie (BDSX) Neueste Nachrichten

pulisher
01:17 AM

Biodesix Details Lung Test Momentum, 81% Gross Margin and Growth Plan at Barclays Conference - MarketBeat

01:17 AM
pulisher
Mar 12, 2026

Recap Report: What is the dividend yield of Biodesix IncNew Guidance & Accurate Trade Setup Notifications - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 11, 2026

Biodesix at Barclays Conference: Strategic Growth in Lung Cancer Diagnostics - Investing.com Canada

Mar 11, 2026
pulisher
Mar 09, 2026

Biodesix Earnings Call Signals Growth With Caveats - TipRanks

Mar 09, 2026
pulisher
Mar 08, 2026

Setup Watch: Is Biodesix Inc in a consolidation phase2026 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn

Mar 08, 2026
pulisher
Mar 07, 2026

Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Mar 07, 2026
pulisher
Mar 06, 2026

Biodesix Details Lung Nodule Growth Plan, Primary Care Push at TD Cowen Healthcare Conference - MarketBeat

Mar 06, 2026
pulisher
Mar 05, 2026

What analysts say about Biodesix Inc stock2025 Dividend Review & Daily Stock Momentum Reports - baoquankhu1.vn

Mar 05, 2026
pulisher
Mar 05, 2026

How The Biodesix (BDSX) Investment Story Is Shifting After Guidance And New US$30 Target - Yahoo Finance

Mar 05, 2026
pulisher
Mar 03, 2026

Wall Street experts predict that Biodesix (BDSX) may climb by 111.62%: Consider this information before making an investment decision - Bitget

Mar 03, 2026
pulisher
Mar 03, 2026

Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a Bet - Finviz

Mar 03, 2026
pulisher
Mar 03, 2026

Are Medical Stocks Lagging Biodesix (BDSX) This Year? - Yahoo Finance

Mar 03, 2026
pulisher
Mar 03, 2026

BDSX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Monashee Investment Management Cuts Biodesix Stake by 95% - National Today

Mar 03, 2026
pulisher
Mar 02, 2026

Are healthcare stocks underperforming Biodesix (BDSX) so far this year? - Bitget

Mar 02, 2026
pulisher
Mar 02, 2026

Canaccord reiterates Biodesix stock rating on strong Q4 results By Investing.com - Investing.com Canada

Mar 02, 2026
pulisher
Mar 02, 2026

Canaccord reiterates Biodesix stock rating on strong Q4 results - Investing.com

Mar 02, 2026
pulisher
Mar 01, 2026

Biodesix (BDSX) Q4 2025 Earnings Call Transcript - AOL.com

Mar 01, 2026
pulisher
Mar 01, 2026

Monashee Investment Management LLC Cuts Holdings in Biodesix, Inc. $BDSX - MarketBeat

Mar 01, 2026
pulisher
Feb 28, 2026

Q4 2025 Biodesix Inc Earnings Call Transcript - GuruFocus

Feb 28, 2026
pulisher
Feb 28, 2026

William Blair Upgrades Biodesix (BDSX) - Nasdaq

Feb 28, 2026
pulisher
Feb 27, 2026

William Blair Upgrades BDSX (Biodesix, Inc.) to Outperform Feb 2026 - Meyka

Feb 27, 2026
pulisher
Feb 27, 2026

Biodesix (NASDAQ:BDSX) Announces Quarterly Earnings Results, Beats Estimates By $0.56 EPS - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

William Blair Upgrades Biodesix (BDSX) to 'Outperform' | BDSX St - GuruFocus

Feb 27, 2026
pulisher
Feb 27, 2026

Biodesix expects 2026 sales to crack $100M - BizWest

Feb 27, 2026
pulisher
Feb 27, 2026

Biodesix, Inc. (BDSX) Q4 2025 Earnings Call Transcript Summary - 富途牛牛

Feb 27, 2026
pulisher
Feb 27, 2026

William Blair Upgrades Biodesix to Outperform From Market Perform - marketscreener.com

Feb 27, 2026
pulisher
Feb 27, 2026

GSA Capital Partners LLP Has $365,000 Stake in Biodesix, Inc. $BDSX - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

William Blair upgrades Biodesix stock rating on execution momentum By Investing.com - Investing.com Australia

Feb 27, 2026
pulisher
Feb 27, 2026

Earnings call transcript: Biodesix Q4 2025 shows strong revenue growth and positive EBITDA By Investing.com - Investing.com South Africa

Feb 27, 2026
pulisher
Feb 27, 2026

William Blair upgrades Biodesix stock rating on execution momentum - Investing.com Nigeria

Feb 27, 2026
pulisher
Feb 27, 2026

Biodesix Inc (BDSX) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus

Feb 27, 2026
pulisher
Feb 26, 2026

Biodesix, Inc. Q4 Loss Drops - Nasdaq

Feb 26, 2026
pulisher
Feb 26, 2026

Biodesix Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Earnings call transcript: Biodesix Q4 2025 shows strong revenue growth and positive EBITDA - Investing.com India

Feb 26, 2026
pulisher
Feb 26, 2026

BDSX Projects 80% Gross Margin and Revenue Growth for FY26 - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

Biodesix Inc (NASDAQ:BDSX) Reports Q4 2025 Earnings Beat and First Adjusted EBITDA Profitability - ChartMill

Feb 26, 2026
pulisher
Feb 26, 2026

Biodesix Q4 Earnings Call Highlights - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Biodesix (BDSX) Surpasses Revenue Expectations in Q4 with 41% Gr - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

Biodesix, Inc. (BDSX) Reports Q4 Loss, Beats Revenue Estimates - Nasdaq

Feb 26, 2026
pulisher
Feb 26, 2026

Biodesix Inc. (BDSX) Stock Falls on Q4 2025 Earnings - Quiver Quantitative

Feb 26, 2026
pulisher
Feb 26, 2026

Biodesix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Biodesix (NASDAQ: BDSX) hits first positive EBITDA on 41% Q4 growth - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

BRIEF-Biodesix Q4 Adjusted Operating Expenses USD 25.8 Million - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Biodesix, Inc. (BDSX) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget

Feb 26, 2026
pulisher
Feb 25, 2026

Earnings To Watch: Biodesix Inc (BDSX) Reports Q4 2025 Result - GuruFocus

Feb 25, 2026
pulisher
Feb 24, 2026

Biodesix to Participate in Upcoming Investor Conferences - Caledonian Record

Feb 24, 2026
diagnostics_research LH
$263.80
price up icon 0.34%
diagnostics_research DGX
$199.70
price down icon 0.59%
diagnostics_research MTD
$1,173.74
price up icon 0.49%
$187.85
price down icon 1.29%
diagnostics_research IQV
$164.72
price up icon 1.10%
diagnostics_research WAT
$286.57
price up icon 1.15%
Kapitalisierung:     |  Volumen (24h):